Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

β-Sitosterol may help prevent heart disease, cancer, and diabetes, but more human studies are needed.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Cerebronal® may help improve certain brain health markers.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Letrozole may help prevent seizures by reducing certain hormone levels.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Phellodendri Cortex Extract may help treat enlarged prostate.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Blocking mTORC1 reduces skin tumor growth in mice.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Certain drugs that block specific enzymes can help treat prostate diseases.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.